Latest Management Fees News

VanEck Investments Limited has issued a comprehensive Replacement Product Disclosure Statement for its suite of 27 ETFs on the ASX, updating investment strategies, fee structures, risk factors, and operational details.

International Equities Corporation Ltd (ASX:IEQ) posted a modest profit for the June 2026 quarter, reversing prior losses amid a challenging economic backdrop that forced the company to exit its hotel and tourism activities.

Imperial Pacific Limited reported a robust 26.5% rise in net worth to $13.5 million for the year ending June 2026, driven by strong investment portfolio growth and a $221,000 capital raise.

ECP Emerging Growth Limited rebounded in the June quarter with a 6.1% portfolio gain and an 8.4% lift in net tangible asset value, driven by strong performances in AI-related holdings and consumer growth stocks.

Income Asset Management Group (ASX:IAM) closed FY2026 Q4 with a record $2.12 billion in trade turnover and resolved key fraud and litigation matters, while its Managed Discretionary Account grew to $23 million.

GQG Partners reported a decline in funds under management to USD 156 billion as of June 30, 2026, driven by net outflows of USD 15.1 billion in the first half of the year. Positive investment returns partially offset the outflows, but strategies underperformed benchmarks over the period.

Titanium Sands Limited (ASX:TSL) has launched a fully underwritten offer of up to 242.7 million New Options to holders of its expired TSLOA Options, aiming to raise approximately $243,000 before expenses. The offer includes a substantial bonus component and options allocated to CPS Capital as fees for managing a $1.2 million loan.

Tyranna Resources has secured $1.075 million through a discounted share placement and options, aiming to fund exploration and working capital for its Angola projects, including the Chinguar Gold Project.

Global X Management (AUS) Limited is trimming the management fee for its Australia 300 ETF (ASX: A300) by 25%, effective 1 July 2026, reflecting a subtle but meaningful cost saving for investors.

Iperion Limited trimmed its net loss to $294,595 for the year to March 2026, aided by waived manufacturing fees and waived licence performance targets, while securing a $250,000 loan facility to underpin ongoing development of its antimicrobial Pathoglaze product.

American Tungsten & Antimony Ltd has inked an underwriting deal with GBA Capital to ensure full subscription of up to 69 million AT4N options expiring this month, securing potential capital injection amid its US critical minerals push.

Booster Innovation Fund reported a $1.593 million profit for the year ended March 2026, supported by increased net assets. However, valuation risks persist due to early-stage investments and recent capital raises at lower prices.